|
1
|
Bedaiwy MA, Alfaraj S, Yong P and Casper
R: New developments in the medical treatment of endometriosis.
Fertil Steril. 107:555–565. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Busacca M and Vignali M: Ovarian
endometriosis: From pathogenesis to surgical treatment. Curr Opin
Obstet Gynecol. 15:321–326. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Redwine DB: Ovarian endometriosis: A
marker for more extensive pelvic and intestinal disease. Fertil
Steril. 72:310–315. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Velebil P, Wingo PA, Xia Z, Wilcox LS and
Peterson HB: Rate of hospitalization for gynecologic disorders
among reproductive-age women in the United States. Obstet Gynecol.
86:764–769. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shozu M, Murakami K and Inoue M: Aromatase
and leiomyoma of the uterus. Semin Reprod Med. 22:51–60. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Al-Hendy A, Diamond MP, Boyer TG and
Halder SK: Vitamin D3 inhibits Wnt/β-catenin and mTOR signaling
pathways in human uterine fibroid cells. J Clin Endocrinol Metab.
101:1542–1551. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ferenczy A: Pathophysiology of
adenomyosis. Hum Reprod Update. 4:312–322. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vercellini P, Viganò P, Somigliana E,
Daguati R, Abbiati A and Fedele L: Adenomyosis: Epidemiological
factors. Best Pract Res Clin Obstet Gynaecol. 20:465–477. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Matalliotakis IM, Cakmak H, Koumantakis
EE, Margariti A, Neonaki M and Goumenou AG: Arguments for a left
lateral predisposition of endometrioma. Fertil Steril. 91:975–978.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
American Society for Reproductive, .
Revised American Society for Reproductive Medicine classification
of endometriosis: 1996. Fertil Steril. 67:817–821. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Russell P: Surface epithelial-stromal
tumors of the ovaryBlaustein's Pathology of the Female Genital
Tract. Kurman RJ: 4th. Springer; New York, NY: pp. 705–782. 1994,
View Article : Google Scholar
|
|
12
|
Mahnert N, Morgan D, Campbell D, Johnston
C and As-Sanie S: Unexpected gynecologic malignancy diagnosed after
hysterectomy performed for benign indications. Obstet Gynecol.
125:397–405. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Verit FF and Yucel O: Endometriosis,
leiomyoma and adenomyosis: The risk of gynecologic malignancy.
Asian Pac J Cancer Prev. 14:5589–5597. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nisolle M and Donnez J: Peritoneal
endometriosis, ovarian endometriosis, and adenomyotic nodules of
the rectovaginal septum are three different entities. Fertil
Steril. 68:585–596. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Motta PM, Van Blerkom J and Mekabe S:
Changes in the surface morphology of ovarian germinal epithelium
during the reproductive life and in some pathological conditions. J
Submicrosc Cytol. 99:664–667. 1992.
|
|
16
|
Jenkins S, Olive DL and Haney AF:
Endometriosis: Pathogenetic implications of the anatomic
distribution. Obstet Gynecol. 67:335–338. 1986.PubMed/NCBI
|
|
17
|
Vercellini P, Aimi G, De Giorgi O,
Maddalena S, Carinelli S and Crosignani PG: Is cystic ovarian
endometriosis an asymmetric disease? Br J Obstet Gynaecol.
105:1018–1021. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Al-Fozan H and Tulandi T: Left lateral
predisposition of endometriosis and endometrioma. Obstet Gynecol.
101:164–166. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mechsner S, Grum B, Gericke C,
Loddenkemper C, Dudenhausen JW and Ebert AD: Possible roles of
oxytocin receptor and vasopressin-1α receptor in the pathomechanism
of dysperistalsis and dysmenorrhea in patients with adenomyosis
uteri. Fertil Steril. 94:2541–2546. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kang S, Li SZ, Wang N, Zhou RM, Wang T,
Wang DJ, Li XF, Bui J and Li Y: Association between genetic
polymorphisms in fibroblast growth factor (FGF)1 and FGF2 and risk
of endometriosis and adenomyosis in Chinese women. Hum Reprod.
25:1806–1811. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Goumenou AG, Arvanitis DA, Matalliotakis
IM, Koumantakis EE and Spandidos DA: Loss of heterozygosity in
adenomyosis on hMSH2, hMLH1, p16Ink4 and GALT loci. Int J Mol Med.
6:667–671. 2000.PubMed/NCBI
|
|
22
|
Mehasseb MK, Panchal R, Taylor AH, Brown
L, Bell SC and Habiba M: Estrogen and progesterone receptor isoform
distribution through the menstrual cycle in uteri with and without
adenomyosis. Fertil Steril. 95:2228–2235, 2235.e1. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sorsa T, Tjäderhane L and Salo T: Matrix
metalloproteinases (MMPs) in oral diseases. Oral Dis. 10:311–318.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Inagaki N, Ung L, Otani T, Wilkinson D and
Lopata A: Uterine cavity matrix metalloproteinases and cytokines in
patients with leiomyoma, adenomyosis or endometrial polyp. Eur J
Obstet Gynecol Reprod Biol. 111:197–203. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kiyomizu M, Kitawaki J, Obayashi H, Ohta
M, Koshiba H, Ishihara H and Honjo H: Association of two
polymorphisms in the peroxisome proliferator-activated
receptor-gamma gene with adenomyosis, endometriosis, and
leiomyomata in Japanese women. J Soc Gynecol Investig. 13:372–377.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kado N, Kitawaki J, Obayashi H, Ishihara
H, Koshiba H, Kusuki I, Tsukamoto K, Hasegawa G, Nakamura N,
Yoshikawa T and Honjo H: Association of the CYP17 gene and CYP19
gene polymorphisms with risk of endometriosis in Japanese women.
Hum Reprod. 17:897–902. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hsieh YY, Chang CC, Tsai FJ, Lin CC and
Tsai CH: T homozygote and allele of epidermal growth factor
receptor 2073 gene polymorphism are associated with higher
susceptibility to endometriosis and leiomyomas. Fertil Steril.
83:796–799. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hsieh YY, Lee CC, Chang CC, Wang YK, Yeh
LS and Lin CS: Angiotensin I-converting enzyme insertion-related
genotypes and allele are associated with higher susceptibility of
endometriosis and leiomyoma. Mol Reprod Dev. 74:808–814. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Q, Li Y, Zhao J, Zhou RM, Wang N, Sun
DL, Duan YN and Kang S: Association of single nucleotide
polymorphisms in VEGF gene with the risk of endometriosis and
adenomyosis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 26:165–169.
2009.(In Chinese). PubMed/NCBI
|
|
30
|
Kang S, Wang Y, Zhang JH, Jin X, Fang SM
and Li Y: Single nucleotide polymorphism in the matrix
metalloproteinases promoter is associated with susceptibility to
endometriosis and adenomyosis. Zhonghua Fu Chan Ke Za Zhi.
40:601–604. 2005.(In Chinese). PubMed/NCBI
|
|
31
|
Shan K, Lian-Fu Z, Hui D, Wei G, Na W, Xia
J and Yan L: Polymorphisms in the promoter regions of the matrix
metalloproteinases-7, −9 and the risk of endometriosis and
adenomyosis in China. Mol Hum Reprod. 12:35–39. 2006. View Article : Google Scholar : PubMed/NCBI
|
